Atlas Trials

Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis

Clinical trial NCT02837146 · UNKNOWN

Trial details

NCT number
NCT02837146
Sponsor
Maria Stoenoiu
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2015-12-01
Primary completion
2018-12-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.